Table 4

Comparison of changes in cardiovascular disease risk between intervention and control groups at 18-month follow-up
N Baseline 18-month Intervention vs. Control
Mean ± S.D. Mean ± S.D. Difference P-valuea
Weight, kg Intervention 238 65.4 ± 7.9 63.8 ± 8.2 -1.08 0.003
Control 1040 66.0 ± 8.7 65.4 ± 9.2
BMI, kg/m2 Intervention 238 25.7 ± 2.2 25.1 ± 2.3 -0.38 0.007
Control 1040 25.7 ± 2.3 25.5 ± 2.6
Waist, cm Intervention 238 90.8 ± 5.7 88.9 ± 6.5 -1.13 0.039
Control 1040 90.6 ± 5.9 90.0 ± 6.7
SBP, mmHg Intervention 238 133.9 ± 14.5 131.2 ± 14.0 -0.91 0.520
Control 1040 135.2 ± 16.1 132.4 ± 14.8
DBP, mmHg Intervention 238 79.6 ± 9.6 78.1 ± 9.0 0.27 0.778
Control 1040 80.7 ± 10.5 78.4 ± 9.9
HDL-C, mg/dl Intervention 238 58.6 ± 15.0 58.6 ± 14.8 1.10 0.214
Control 1040 56.6 ± 15.1 56.3 ± 15.3
LDL-C, mg/dl Intervention 238 134.2 ± 29.1 127.0 ± 27.9 0.59 0.823
Control 1040 133.9 ± 31.5 127.5 ± 31.7
TG, mg/dl Intervention 238 143.6 ± 74.2 136.5 ± 76.2 -25.1 0.021
Control 1040 163.4 ± 131.1 156.7 ± 119.4
HbA1c,% Intervention 238 5.32 ± 0.39 5.31 ± 0.39 -0.03 0.429
Control 1040 5.35 ± 0.66 5.38 ± 0.57
Framingham risk score, score Intervention 238 13.9 ± 2.4 14.0 ± 2.5 -0.39 0.022
Control 1040 13.9 ± 2.7 14.1 ± 2.9
Mean 10-year CHD risk,% Intervention 238 8.7 ± 5.8 8.8 ± 5.9 -0.85 0.027
Control 1040 9.3 ± 6.4 9.8 ± 6.6

BMI = body mass index, waist = waist circumference, SBP = systolic blood pressure, DBP = diastolic blood pressure, HDL-C = high-density lipoprotein cholesterol, LDL-C = low-density lipoprotein cholesterol, TG = Triglycerides, HbA1c = Hemoglobin, CHD = coronary heart disease.

aby covariance analysis adjusted for baseline values, age, sex and intervention times.

Zhu et al.

Zhu et al. BMC Public Health 2013 13:219   doi:10.1186/1471-2458-13-219

Open Data